Kepos Capital LP Vertex Pharmaceuticals Inc Transaction History

Kepos Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $798,480 - $990,496	-3,997 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $199,885 - $268,468	1,199 Added 42.85%	3,997 $875,000
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $546,896 - $615,526	-3,290 Reduced 54.04%	2,798 $474,000
Q2 2019 Aug 13, 2019	BUY	$164.61 - $190.37 $1 Million - $1.16 Million	6,088 New	6,088 $1.12 Million
Q4 2018 Feb 13, 2019	SELL	$151.91 - $192.21 $3.72 Million - $4.71 Million	-24,513 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $1.52 Million - $1.75 Million	-9,081 Reduced 27.03%	24,513 $4.73 Million
Q2 2018 Aug 13, 2018	BUY	$145.72 - $169.96 $3.23 Million - $3.77 Million	22,198 Added 194.79%	33,594 $5.71 Million
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $45,631 - $53,316	-301 Reduced 2.57%	11,396 $1.86 Million
Q4 2017 Feb 12, 2018	BUY	$137.28 - $155.55 $1.61 Million - $1.82 Million	11,697	11,697 $1.75 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.